by Cervical dystonia (CD), also known as spasmodic torticollis, is a neurological movement disorder in which involuntary muscle contractions cause abnormal posture and twisting of the neck. Some key symptoms of CD include stiffness and spasms in the neck muscles, abnormal head positioning such as forward tilt or a twisted neck. CD has a significant impact on a person’s quality of life and routine activities such as driving, working, sleeping and socializing. Deep brain stimulation (DBS) therapy delivered via implantable medical devices has proven to be an effective treatment option for reducing the symptoms of CD over the past years.
The global cervical dystonia market is estimated to be valued at US$ 634.8 million in 2024 and is expected to exhibit a CAGR of 6% over the forecast period 2024-2031.
Key Takeaways
Key players: Key players operating in the cervical dystonia market are Medtronic, Boston Scientific Corporation, St. Jude Medical, Synapse Biomedical Inc., Neurosigma Inc., Nevro Corporation, and Functional Neuromodulation Ltd.
Key opportunities: Growing awareness regarding advanced treatment and rising incidence rates of cervical dystonia presents significant opportunities for players in the market. Geographical expansion into emerging markets also offers growth prospects over the forecast period.
Technological advancements: Continuous innovation and technological advancements in DBS therapy such as closed-loop DBS systems and brain-computer interfaces are expected to further drive the adoption of new generation stimulation devices and systems for management of cervical dystonia.
Market drivers: Rising geriatric population globally increases the risk of developing cervical dystonia. Growing preference of minimally invasive DBS therapy over oral medication also fuel the market growth. Increasing healthcare expenditure in developing countries facilitates access to modern treatment options and drives the market growth.
Market Drivers
The key driver expected to boost the cervical dystonia market includes rising prevalence of cervical dystonia disorder globally. The risk of developing cervical dystonia increases with age and according to available estimates, an estimated 80,000 Americans suffer from cervical dystonia. Growing geriatric population worldwide thus present increase patient pool. Furthermore, continuous innovation and technological developments in DBS therapy such as minimally invasive procedures and surgical techniques have helped improve the clinical outcomes for cervical dystonia patients. Rising healthcare expenditures being witnessed in developing countries also aids in wider access to advanced and effective treatment modalities for cervical dystonia management.
Current challenges in Cervical Dystonia market:
Cervical dystonia is a neurological disorder where involuntary and painful muscle contractions in the neck occur leading to abnormal neck postures. This makes moving and positioning the neck difficult. It can significantly reduce the patient’s quality of life. Some of the key challenges currently faced in treating cervical dystonia are lack of awareness about the condition especially in developing regions, limited treatment options with only medicines and botox injections being effective for some patients, difficulty in accurately diagnosing the condition as initial symptoms may be confused with other neck issues, and costs associated with long term treatment. More research is required to better understand the exact causes and develop new non-invasive treatment alternatives which are effective for all patients.
SWOT Analysis
Strength: Medicines and botulinum toxin injections provide symptomatic relief for most patients. Increased awareness is leading to more patients seeking timely treatment.
Weakness: Exact causes still unknown making it difficult to prevent or cure. Current treatment options not fully effective for all patients. Expensive long term costs of treatment.
Opportunity: Scope for development of new non-invasive treatment methods like physiotherapy, nerve stimulation therapy etc. Increased focus on R&D can help improve diagnostics and find better medicines.
Threats: Limited healthcare access and awareness in developing regions leads to delayed diagnosis. Cost may be prohibitive for some without insurance coverage. Possible side effects from long term medication use.
The geographical region concentrating the highest value currently in the cervical dystonia market is North America. This is attributed to factors like presence of major market players, high diagnosis and treatment rates supported by good healthcare infrastructure and insurance coverage. Europe is the second largest region driven by initiatives supporting rare disease research and availability of advanced treatment options. Asia Pacific region is emerging as the fastest growing market for cervical dystonia at a CAGR of over 8% owing to improving access to healthcare in countries like China and India coupled with rising disposable incomes. Increasing collaborative research activities between Asia and other regions will further support market growth in Asia Pacific.
*Note:
1. Source: Coherent Market Insights, Public sources, Desk research
2. We have leveraged AI tools to mine information and compile it
Ravina Pandya, a content writer, has a strong foothold in the market research industry. She specializes in writing well-researched articles from different industries, including food and beverages, information and technology, healthcare, chemicals and materials, etc. With an MBA in E-commerce, she has expertise in SEO-optimized content that resonates with industry professionals.
